Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3438491 | American Journal of Obstetrics and Gynecology | 2009 | 7 Pages |
Abstract
We conclude that SPARC is an important extracellular matrix protein that regulates the growth and chemosensitivity of ovarian cancer. In general, SPARC appears to control tumor cell growth but also impede the efficacy of cisplatin therapy. Therefore, selective inhibition of SPARC may provide an attractive strategy for increasing the efficacy of therapy in platinum-resistant ovarian tumors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shawna L. MD, Juliet Carbon, Andrew Miller, Emely PhD, Shanna Arnold, Rolf A. PhD, Jayanthi S. MD,